Cargando…

Patient persistence with first-line antiglaucomatous monotherapy

PURPOSE: To identify the extent of persistence (period of time of continuous therapy with the drug prescribed) of glaucoma patients treated with prostaglandins (latanoprost, bimatoprost, or travoprost), or β-blocker (timolol) monotherapy. METHODS: An observational retrospective study of a 24-month f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Arias, Alfonso, Schargel, Konrad, Ussa, Fernando, Canut, Maria I, Robles, Amelia y Belén, Sánchez, Belén Martí
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2010
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2861932/ https://www.ncbi.nlm.nih.gov/pubmed/20463793

Ejemplares similares

Ocular Surface Alterations and Topical Antiglaucomatous Therapy: A Review
por: Actis, Alessandro G, et al.
Publicado: (2014)

Particulate Systems in the Enhancement of the Antiglaucomatous Drug Pharmacodynamics: A Meta-Analysis Study
por: Hathout, Rania M.
Publicado: (2019)

Regulation of Retinal Proteome by Topical Antiglaucomatous Eye Drops in an Inherited Glaucoma Rat Model
por: Schallenberg, Maurice, et al.
Publicado: (2012)

Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
por: Lajmi, Houda, et al.
Publicado: (2021)

The Effect of Long-Term Usage of Single-Agent Antiglaucomatous Drops with Different Preservatives on Cornea Biomechanics
por: Aydemir, Gozde Aksoy, et al.
Publicado: (2021)

Cómo transformar la educación a través de la gestión de la calidad total : guía práctica /
por: Schargel, Franklin P.
Publicado: (1997)

Complete remission of advanced lung adenocarcinoma with first-line pembrolizumab monotherapy: Two case reports
por: Gohara, Kazuki, et al.
Publicado: (2021)

Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs
por: Lenotti, Elisa, et al.
Publicado: (2021)

First-line csDMARD monotherapy drug retention in psoriatic arthritis: methotrexate outperforms sulfasalazine
por: Jacobs, Marleen E, et al.
Publicado: (2020)

Tube Revision Outcomes for Exposure with Different Repair Techniques
por: Alawi, Abeer, et al.
Publicado: (2020)

Short term outcomes of topiramate monotherapy as a first-line treatment in newly diagnosed West syndrome
por: Lee, Gyu Min, et al.
Publicado: (2011)

Environmental DNA persistence and fish detection in captive sponges
por: Cai, Wang, et al.
Publicado: (2022)

First-line chemotherapy in very elderly patients with metastatic pancreatic cancer: Gemcitabine monotherapy vs combination chemotherapy
por: Han, Sung Yong, et al.
Publicado: (2020)

Prediction of patients with a tumor proportion score > 50% who do not respond to first-line monotherapy with pembrolizumab
por: Morita, Mitsunori, et al.
Publicado: (2020)

Rituximab Monotherapy Is Effective as First-Line Treatment for Granulomatous Lymphocytic Interstitial Lung Disease (GLILD) in CVID Patients
por: Tessarin, Giulio, et al.
Publicado: (2023)

Persistent Head and Neck Cancer Following First-Line Treatment
por: Steinbichler, Teresa Bernadette, et al.
Publicado: (2018)

A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 Plus Cisplatin as a Second-line Therapy, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second Report
por: Rino, Yasushi, et al.
Publicado: (2010)

Olaparib First-Line Maintenance Monotherapy in BRCA-Mutated Epithelial Ovarian Cancer: Descriptive Analysis of the First French Real-World Data Study
por: Bellier, Charlotte, et al.
Publicado: (2023)

Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data
por: Schmid, Sabine, et al.
Publicado: (2019)

Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapy
por: Tokudome, Nahomi, et al.
Publicado: (2020)

Efficacy and safety of first-line combination therapy versus monotherapy for vitreoretinal lymphoma: a systematic review and meta-analysis
por: Gao, Jing, et al.
Publicado: (2023)

Development of a new algorithm based on FDT Matrix perimetry and SD-OCT to improve early glaucoma detection in primary care
por: Morejon, Angela, et al.
Publicado: (2018)

Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy
por: Patel, Bimal V, et al.
Publicado: (2008)

Avelumab monotherapy as first-line or second-line treatment in patients with metastatic renal cell carcinoma: phase Ib results from the JAVELIN Solid Tumor trial
por: Vaishampayan, Ulka, et al.
Publicado: (2019)

Efficacy and safety of endocrine monotherapy as first-line treatment for hormone-sensitive advanced breast cancer: A network meta-analysis
por: Zhang, Jingwen, et al.
Publicado: (2017)

Comparative Economic Outcomes in Patients with Focal Seizure Initiating First-Line Eslicarbazepine Acetate Monotherapy versus Generic Antiseizure Drugs
por: Mehta, Darshan, et al.
Publicado: (2021)

Third-Line Nivolumab Monotherapy in Recurrent SCLC: CheckMate 032
por: Ready, Neal, et al.
Publicado: (2018)

Phase II study of everolimus (RAD001) monotherapy as first-line treatment in advanced biliary tract cancer with biomarker exploration: the RADiChol Study
por: Lau, David K., et al.
Publicado: (2018)

Surgical rescue for persistent head and neck cancer after first-line treatment
por: Steinbichler, Teresa Bernadette, et al.
Publicado: (2020)

Ranibizumab in monotherapy and combined with photodynamic therapy for retinal angiomatous proliferation
por: Arias, Luis, et al.
Publicado: (2016)

First-Line Treatment with Carboplatin plus nab-Paclitaxel and Maintenance Monotherapy with nab-Paclitaxel for a Thymic Carcinoma: A Case Report
por: Funaishi, Kunihiko, et al.
Publicado: (2017)

Efficacy of EGFR-TKI Plus Chemotherapy or Monotherapy as First-Line Treatment for Advanced EGFR-Mutant Lung Adenocarcinoma Patients With Co-Mutations
por: Yang, Zhengyu, et al.
Publicado: (2021)

Atezolizumab Monotherapy or Plus Chemotherapy in First-Line Treatment for Advanced Non-Small Cell Lung Cancer Patients: A Meta-Analysis
por: Li, Dan-Ni, et al.
Publicado: (2021)

Lenvatinib Plus Camrelizumab vs. Lenvatinib Monotherapy as First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study
por: Li, Qi, et al.
Publicado: (2022)

Doxorubicin/Adriamycin Monotherapy or Plus Ifosfamide in First-Line Treatment for Advanced Soft Tissue Sarcoma: A Pooled Analysis of Randomized Trials
por: Wang, Bi-Cheng, et al.
Publicado: (2021)

The effectiveness of nab-paclitaxel plus gemcitabine and gemcitabine monotherapy in first-line metastatic pancreatic cancer treatment: A real-world evidence
por: Prejac, Juraj, et al.
Publicado: (2022)

Impact of Frailty on Outcomes of First-Line Pembrolizumab Monotherapy in a Real-World Population with Advanced Non-Small Cell Lung Cancer
por: Jiménez Galán, Rocío, et al.
Publicado: (2023)

Effect of different monotherapies on serum nitric oxide and pulmonary functions in children with mild persistent asthma
por: Radwan, Zeinab Mohamed, et al.
Publicado: (2010)

Vancomycin monotherapy vs. combination therapy for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia
por: Seah, Jonathan, et al.
Publicado: (2013)

PS100. Open-label Desvenlafaxine as Monotherapy for Persistent Depression Disorder: A Pilot Study
por: Ravindran, Arun V., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oqjrtnc37it2f20h9su047pise